Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

61.20 3.14 +5.41%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.34%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
5 5 3 4

+8 more TTM periods

ROE
(7.04%) (5.07%) (1.69%) (1.05%)
ROA
(2.73%) (1.73%) (0.60%) (0.37%)
ROIC
(1.12%) (0.47%) 0.73% 1.05%
Return on Tangible Assets
(9.95%) (6.16%) (2.48%) (1.34%)
Average Days of Receivables
58.59 56.94 57.28 57.88
Free Cash Flow per Share
1.60 0.62 0.34 0.29
Free Cash Flow
244.70 93.90 51.30 43.30
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026